Shir Abramovitz

Shir Abramovitz has a diverse work experience spanning several industries. They began their career in the IDF as an Instructor and Commander in the Artillery division from December 2009 to December 2011. Afterward, they joined Neuroderm as a Research Assistant, where they assisted in managing clinical trials databases and conducted lab experiments from December 2017 to May 2018. Following this, Shir joined Bioforum the Data Masters, starting as a Business Development Associate from May 2018 to December 2019. In this role, they identified potential alliances, developed marketing materials, and maintained the company's website. They then transitioned to the role of Quality Assurance Associate from May 2018 to December 2019, where they monitored compliance, supported SOPs preparation, and handled deviations and investigations. Lastly, Shir became a Quality Assurance Manager at Bioforum the Data Masters from January 2020 to December 2021. In this role, they managed a team, oversaw quality assurance processes, and maintained necessary documentation. Currently, Shir is employed at Dot Compliance, where they began as a Customer Success Manager from December 2021 to December 2022. They built and maintained client relationships, established retention goals, and assisted with system setup and navigation. In January 2023, Shir transitioned to the position of Project Manager, Professional Services at Dot Compliance.

Shir Abramovitz earned a Bachelor of Science (B.Sc) degree in Nutrition Sciences from The Hebrew University of Jerusalem, which was completed between the years 2015 and 2018. Prior to that, between 2007 and 2009, Shir attended Ben Gurion high school, although no specific degree or field of study is mentioned for this period. In 2018, Shir completed the ICH-GCP CRA Course in Clinical Research at Bioforum Applied Knowledge Center. Currently, Shir is pursuing a Master of Business Administration (MBA) degree with a specialization in biomed at The Hebrew University of Jerusalem, which is expected to be completed between 2020 and 2022.